title: Sulbutiamine counteracts trophic factor deprivation induced apoptotic cell death in transformed retinal ganglion cells.
abstract: Sulbutiamine is a highly lipid soluble synthetic analogue of vitamin B(1) and is used clinically for the treatment of asthenia. The aim of our study was to demonstrate whether sulbutiamine is able to attenuate trophic factor deprivation induced cell death to transformed retinal ganglion cells (RGC-5). Cells were subjected to serum deprivation for defined periods and sulbutiamine at different concentrations was added to the cultures. Various procedures (e.g. cell viability assays, apoptosis assay, reactive oxygen species analysis, Western blot analysis, flow cytometric analysis, glutathione (GSH) and glutathione-S-transferase (GST) measurement) were used to demonstrate the effect of sulbutiamine. Sulbutiamine dose-dependently attenuated apoptotic cell death induced by serum deprivation and stimulated GSH and GST activity. Moreover, sulbutiamine decreased the expression of cleaved caspase-3 and AIF. This study demonstrates for the first time that sulbutiamine is able to attenuate trophic factor deprivation induced apoptotic cell death in neuronal cells in culture.
authors.affiliation: Department of Ophthalmology, Oxford Eye Hospital, University of Oxford, Headington, Oxford, UK.
authors.forename: Kui Dong
authors.initials: KD
authors.lastname: Kang
authors.forename: Aman Shah Abdul
authors.initials: AS
authors.lastname: Majid
authors.forename: Kyung-A
authors.initials: KA
authors.lastname: Kim
authors.forename: Kyungsu
authors.initials: K
authors.lastname: Kang
authors.forename: Hong Ryul
authors.initials: HR
authors.lastname: Ahn
authors.forename: Chu Won
authors.initials: CW
authors.lastname: Nho
authors.forename: Sang Hoon
authors.initials: SH
authors.lastname: Jung
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D051033:Apoptosis Inducing Factor / Q000378:metabolism; D053148:Caspase 3 / Q000378:metabolism; D002461:Cell Line, Transformed; D002470:Cell Survival / Q000187:drug effects; D016895:Culture Media, Serum-Free / Q000494:pharmacology; D005978:Glutathione / Q000378:metabolism; D051379:Mice; D017382:Reactive Oxygen Species / Q000378:metabolism; D012165:Retinal Ganglion Cells / Q000187:drug effects*; D013831:Thiamine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D051033:Apoptosis Inducing Factor; D016895:Culture Media, Serum-Free; C494830:AIFM1 protein, mouse; D017382:Reactive Oxygen Species; C031331:sulbutiamine; D053148:Caspase 3; D005978:Glutathione; D013831:Thiamine
references.citation: Intern Med. 1997 Jul;36(7):532
references.pmid: 9240508
references.citation: Photosynth Res. 2005 Dec;86(3):435-57
references.pmid: 16315075
references.citation: Curr Opin Ophthalmol. 2002 Apr;13(2):61-7
references.pmid: 11880717
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Jun;292(6):L1515-25
references.pmid: 17337508
references.citation: Mol Pharmacol. 2004 Nov;66(5):1113-22
references.pmid: 15304547
references.citation: Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2660-7
references.pmid: 10509663
references.citation: Free Radic Biol Med. 2008 Aug 15;45(4):367-76
references.pmid: 18489911
references.citation: Brain Res Mol Brain Res. 2001 Jan 31;86(1-2):1-12
references.pmid: 11165366
references.citation: Am J Manag Care. 2008 Feb;14(1 Suppl):S15-9
references.pmid: 18284311
references.citation: Invest Ophthalmol Vis Sci. 2005 Mar;46(3):877-83
references.pmid: 15728543
references.citation: Prog Retin Eye Res. 2006 Sep;25(5):490-513
references.pmid: 16962364
references.citation: Vision Res. 2007 Apr;47(9):1191-201
references.pmid: 17306853
references.citation: Basic Clin Pharmacol Toxicol. 2008 Nov;103(5):482-6
references.pmid: 18715237
references.citation: J Biol Chem. 1994 May 20;269(20):14379-85
references.pmid: 8182042
references.citation: Neurosci Lett. 2000 Sep 29;292(1):49-53
references.pmid: 10996447
references.citation: Pharmacol Biochem Behav. 1985 Aug;23(2):195-8
references.pmid: 4059305
references.citation: Cell Mol Life Sci. 2003 Jul;60(7):1477-88
references.pmid: 12943234
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Brain Res. 2007 Jul 16;1158:158-63
references.pmid: 17555724
references.citation: Surv Ophthalmol. 2008 Sep-Oct;53(5):479-505
references.pmid: 18929760
references.citation: Mutat Res. 2006 Mar;612(2):105-14
references.pmid: 16413223
references.citation: World J Biol Psychiatry. 2006;7(3):183-5
references.pmid: 16861144
references.citation: Arch Ophthalmol. 2003 Jan;121(1):48-56
references.pmid: 12523884
references.citation: Brain Res. 1994 Jul 25;652(1):157-60
references.pmid: 7953714
references.citation: Annu Rev Biochem. 1983;52:711-60
references.pmid: 6137189
references.citation: Prog Retin Eye Res. 2004 Jan;23(1):91-147
references.pmid: 14766318
references.citation: Brain Res. 2009 Jan 28;1251:269-75
references.pmid: 19056360
references.citation: Prog Retin Eye Res. 1999 Jan;18(1):39-57
references.pmid: 9920498
references.citation: Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1330-8
references.pmid: 15790899
references.citation: Ann Ophthalmol. 1979 Jul;11(7):1095-1100
references.pmid: 485004
references.citation: Ann Pharmacother. 1995 Dec;29(12):1263-73
references.pmid: 8672832
references.citation: Biochem Pharmacol. 1990 Dec 1;40(11):2557-60
references.pmid: 2268373
references.citation: J Assoc Physicians India. 2003 Sep;51:891-5
references.pmid: 14710977
references.citation: Physiol Rev. 2002 Jan;82(1):47-95
references.pmid: 11773609
references.citation: Exp Eye Res. 2007 Mar;84(3):389-99
references.pmid: 17196589
references.citation: Urologiia. 2005 Jan-Feb;(1):32-5
references.pmid: 15776829
references.citation: Methods Enzymol. 1995;251:203-12
references.pmid: 7651198
references.citation: Invest Ophthalmol Vis Sci. 2010 Jan;51(1):284-94
references.pmid: 19710416
references.citation: Am J Physiol. 1989 Oct;257(4 Pt 1):L163-73
references.pmid: 2572174
references.citation: Brain Res. 2007 Jul 23;1159:40-53
references.pmid: 17573045
references.citation: Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4267-72
references.pmid: 19443730
references.citation: Can J Ophthalmol. 2007 Jun;42(3):425-38
references.pmid: 17508040
references.citation: Encephale. 2007 Mar-Apr;33(2):211-5
references.pmid: 17675917
references.citation: Drugs Today (Barc). 1999 Mar;35(3):187-92
references.pmid: 12973384
references.citation: Cancer Lett. 2003 Dec 30;202(2):125-9
references.pmid: 14643441
references.citation: Proc Natl Acad Sci U S A. 1981 Sep;78(9):5886-9
references.pmid: 6272323
references.citation: Life Sci. 2009 Jan 2;84(1-2):28-32
references.pmid: 18992261
references.citation: Chem Biol Interact. 2007 Jan 30;165(2):146-54
references.pmid: 17207784
references.citation: Curr Opin Ophthalmol. 1999 Apr;10(2):82-92
references.pmid: 10537768
references.citation: Brain Res. 2005 Aug 16;1053(1-2):185-94
references.pmid: 16051195
references.citation: J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):846-7
references.pmid: 18559466